Cohort Profile: ReCoDID Consortiums Harmonized Acute Febrile Illness Arbovirus Meta-Cohort
Gomez, G.; Hufstedler, H.; Montenegro, C.; Roell, Y.; Lozano, A.; Tami, A.; Magalhaes, T.; Marques, E. T. A.; Balmaseda, A.; Calvet, G.; Harris, E.; Brasil, P.; Herrera, V.; Villar, L.; Maxwell, L.; Jaenisch, T.
Show abstract
Infectious disease (ID) cohorts are key to advancing public health surveillance, public policies and pandemic responses. Unfortunately, ID cohorts often lack funding to store and share clinical-epidemiological data (CE) and high-dimensional laboratory (HDL) data long-term, which is evident when the link between these data elements is not kept up to date. This becomes particularly apparent when smaller cohorts fail to successfully address the initial scientific objectives due to limited case numbers, which also limits the potential of pooling for these studies to monitor long-term cross-disease interactions within and across populations. To facilitate advancements in cross-population inference and reuse of cohort data, the European Commission (EC) and the Canadian Institutes of Health Research, Institute of Genetics (CIHR-IG) funded the ReCoDID (Reconciliation of Cohort Data for Infectious Diseases) Consortium to store and share harmonized and standardized CE and HDL data on a federated platform and also provide innovative statistical tools to conduct meta-analyses of the individual patient data. Here we describe the harmonization of CE data from nine arbovirus (arthropod-borne viruses) cohorts in Latin America, which serve as a starting point for the ReCoDID meta-cohort. CE data was retrospectively harmonized using Maelstroms methodology and standardized to Clinical Data Interchange Standards Consortium (CDISC). This meta-cohort will facilitate various joint research projects, e.g., on immunological interactions between sequential flavivirus infections and for the evaluation of potential biomarkers for severe arboviral disease.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua 95%
- Unraveling Regional Variability in Dengue Outbreaks in Brazil: leveraging the Moving Epidemics Method (MEM) and Climate Data to Optimize Vector Control Strategies 95%
- Increasing transmission of dengue virus across ecologically diverse regions of Ecuador and associated risk factors 95%
Similar papers in this journal
- Genomic sequencing and neutralizing serological profiles during acute dengue infection: A 2017 cohort study in Nepal 95%
- Epidemiological and virological factors determining dengue transmission in Sri Lanka during the COVID-19 pandemic 93%
- U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022 93%
Similar papers in this journal
- Cohort Study Protocol of the Brazilian Collaborative Research Network on COVID-19: strengthening WHO global data 92%
- Vaccine Preventable Disease Seroprevalence In a Nationwide Assessment of Timor-Leste (VASINA-TL) - study protocol for a population-representative cross-sectional serosurvey 91%
- Seroprevalence and associated factors of maternal cytomegalovirus in Southern Ethiopia 91%
Similar papers in this journal
- Did COVID-19 or COVID-19 vaccines influence the patterns of Dengue in 2021: An exploratory analysis of two observational studies from North India 94%
- Endemic and epidemic human alphavirus infections in Eastern Panama, An Analysis of Population-Based Cross-Sectional Surveys 93%
- Field efficacy of guppies and pyriproxyfen (Sumilarv(R) 2MR) combined with community engagement on dengue vectors in Cambodia: a randomized controlled trial 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.